https://neuropsychiatric-drug-development.com/ 2026-04-21T15:21:28+00:00 https://neuropsychiatric-drug-development.com/exhibitor/helus-pharma/ 2026-04-21T15:01:51+00:00 https://neuropsychiatric-drug-development.com/exhibitor/definium-therapeutics/ 2026-04-21T15:00:52+00:00 https://neuropsychiatric-drug-development.com/exhibitor/bms/ 2026-04-21T15:00:10+00:00 https://neuropsychiatric-drug-development.com/speaker/andrew-miller/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/sponsor/beacon-psychiatry/ 2026-04-21T10:05:10+00:00 https://neuropsychiatric-drug-development.com/speaker/lawrence-park/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/rouba-kozak/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/eloise-jarvis/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/john-salamone/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/matt-harlin/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/chris-ocampo/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/michael-didriksen/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/guy-goodwin/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/magali-haas/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/scott-thompson/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/enya-paschen/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/marco-pignatelli/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/zoe-hughes/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/peter-stein/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/john-huxter/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/paul-matteis/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/natalie-sacks/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/jason-pitts/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/ritu-baral/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/pranab-kalita/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/shobi-ahmed/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/jordan-smoller/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/sam-banister/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/jenny-barnett/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/jens-wendland/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/mikhail-kalinichev/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/christopher-ocampo/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/chris-weyrer/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/veronika-logonvinsky/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/per-johan-luthman/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/nick-brandon/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/aaron-koenig/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/michael-chen/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/samir-koirala/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/joseph-t-coyle/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/derek-buhl/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/amir-inamdar/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/steve-levine/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/speaker/james-cronican/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/blogs/blog-post-8/ 2026-04-17T07:46:25+00:00 https://neuropsychiatric-drug-development.com/blogs/blog-post-7/ 2026-04-17T07:44:11+00:00 https://neuropsychiatric-drug-development.com/blogs/blog-post-6/ 2026-04-17T07:44:35+00:00 https://neuropsychiatric-drug-development.com/exhibitor/xylo-bio/ 2026-04-15T14:05:56+00:00 https://neuropsychiatric-drug-development.com/exhibitor/neurosterix/ 2026-04-15T14:04:23+00:00 https://neuropsychiatric-drug-development.com/exhibitor/syndeio/ 2026-04-15T13:51:41+00:00 https://neuropsychiatric-drug-development.com/exhibitor/fda/ 2026-04-15T13:49:53+00:00 https://neuropsychiatric-drug-development.com/exhibitor/general-atlantic-and-cowen/ 2026-04-15T13:47:05+00:00 https://neuropsychiatric-drug-development.com/exhibitor/stifel/ 2026-04-15T13:46:15+00:00 https://neuropsychiatric-drug-development.com/exhibitor/vida-ventures/ 2026-04-15T13:45:04+00:00 https://neuropsychiatric-drug-development.com/exhibitor/lilly/ 2026-04-15T13:42:40+00:00 https://neuropsychiatric-drug-development.com/exhibitor/seaport-therapeutics/ 2026-04-15T13:39:02+00:00 https://neuropsychiatric-drug-development.com/exhibitor/harvard-medical-school/ 2026-04-15T13:38:11+00:00 https://neuropsychiatric-drug-development.com/exhibitor/alto-neuroscience/ 2026-04-15T13:37:20+00:00 https://neuropsychiatric-drug-development.com/exhibitor/otsuka/ 2026-04-15T13:11:36+00:00 https://neuropsychiatric-drug-development.com/exhibitor/novo-holdings/ 2026-04-15T13:10:42+00:00 https://neuropsychiatric-drug-development.com/exhibitor/neumora/ 2026-04-15T13:09:59+00:00 https://neuropsychiatric-drug-development.com/exhibitor/monument-therapetuics/ 2026-04-15T13:09:15+00:00 https://neuropsychiatric-drug-development.com/exhibitor/karuna-therapeutics/ 2026-04-15T13:08:44+00:00 https://neuropsychiatric-drug-development.com/exhibitor/lundbeck/ 2026-04-15T13:07:27+00:00 https://neuropsychiatric-drug-development.com/exhibitor/gilgamesh/ 2026-04-15T13:06:48+00:00 https://neuropsychiatric-drug-development.com/exhibitor/compass-pathways/ 2026-04-15T13:06:09+00:00 https://neuropsychiatric-drug-development.com/exhibitor/boehringer-ingelheim/ 2026-04-15T13:05:26+00:00 https://neuropsychiatric-drug-development.com/exhibitor/alkermes/ 2026-04-15T13:04:43+00:00 https://neuropsychiatric-drug-development.com/exhibitor/abbvie/ 2026-04-15T13:04:09+00:00 https://neuropsychiatric-drug-development.com/sponsor/synapcell/ 2026-04-21T10:02:36+00:00 https://neuropsychiatric-drug-development.com/sponsor/biotrial/ 2026-04-21T10:01:35+00:00 https://neuropsychiatric-drug-development.com/sponsor/sama-therapeutics/ 2026-04-21T10:00:50+00:00 https://neuropsychiatric-drug-development.com/sponsor/clerkenwell-health/ 2026-04-21T09:59:08+00:00 https://neuropsychiatric-drug-development.com/sponsor/ulysses-neurosciences/ 2026-04-21T16:05:56+00:00 https://neuropsychiatric-drug-development.com/sponsor/transpharmation/ 2026-04-21T09:57:02+00:00 https://neuropsychiatric-drug-development.com/blogs/blog-post-5/ 2026-04-17T07:45:32+00:00 https://neuropsychiatric-drug-development.com/blogs/blog-post-4/ 2026-04-17T07:44:54+00:00 https://neuropsychiatric-drug-development.com/blogs/blog-post-3/ 2026-04-17T07:43:33+00:00 https://neuropsychiatric-drug-development.com/blogs/blog-post-2/ 2026-04-17T07:45:13+00:00 https://neuropsychiatric-drug-development.com/blogs/blog-post-1/ 2026-04-17T07:43:53+00:00 https://neuropsychiatric-drug-development.com/blogs/ 2026-04-21T09:53:13+00:00 https://neuropsychiatric-drug-development.com/about/events-in-the-series/ 2026-04-17T07:41:16+00:00 https://neuropsychiatric-drug-development.com/pre-conference-day/ 2026-04-21T15:08:32+00:00 https://neuropsychiatric-drug-development.com/why-partner/ 2026-04-21T11:35:28+00:00 https://neuropsychiatric-drug-development.com/about/poster-session/ 2026-04-21T10:15:00+00:00 https://neuropsychiatric-drug-development.com/about-event/ 2026-04-21T15:04:52+00:00 https://neuropsychiatric-drug-development.com/thank-you-for-downloading/ 2026-04-17T07:57:41+00:00 https://neuropsychiatric-drug-development.com/thank-you-for-registering/ 2026-04-17T07:58:14+00:00 https://neuropsychiatric-drug-development.com/contact-us/ 2026-04-21T10:36:16+00:00 https://neuropsychiatric-drug-development.com/venue-accommodation/ 2026-04-21T08:47:00+00:00 https://neuropsychiatric-drug-development.com/register/ 2026-04-21T10:09:32+00:00 https://neuropsychiatric-drug-development.com/day-two/ 2026-04-21T13:39:59+00:00 https://neuropsychiatric-drug-development.com/day-one/ 2026-04-21T13:39:06+00:00 https://neuropsychiatric-drug-development.com/full-event-guide/ 2026-04-21T08:51:53+00:00 https://neuropsychiatric-drug-development.com/about/hanson-wade/ 2026-01-28T16:23:10+00:00 https://neuropsychiatric-drug-development.com/home/video-header/ 2025-09-08T09:36:47+00:00 https://neuropsychiatric-drug-development.com/speakers/ 2026-04-20T11:26:04+00:00 https://neuropsychiatric-drug-development.com/partners/ 2026-04-21T10:06:19+00:00 https://neuropsychiatric-drug-development.com/take-part/ 2026-04-17T07:55:56+00:00 https://neuropsychiatric-drug-development.com/about/ 2026-04-17T07:39:51+00:00 https://neuropsychiatric-drug-development.com/seminar/afternoon-networking-break-2/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/end-of-conference/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/chairs-closing-remarks-2/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/panel-discussion-redefining-therapeutic-potential-in-muscarinics-interrogating-the-m1-m4-debate-to-advance-next-generation-neuropsychiatric-treatments/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/advancing-therapeutics-for-psychiatric-disease-novel-targets-the-promise-of-precision-neuroscience/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/a-landscape-review-of-neuropsychiatric-therapy-development/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/evolving-the-regulatory-landscape-to-align-with-precision-psychiatry-initatives/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/afternoon-break-refreshments-2/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/panel-discussion-understanding-anxiety-key-biology-clinical-features-sleep-cross-section-comorbidities/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/transforming-anxiety-mood-disorder-therapeutics-advancing-glyphago-spt-320-spt-300-spt-348-in-next-generation-neuropsychiatric-care/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/circuit-level-mechanisms-of-ketamines-antidepressant-action-from-stress-induced-nucleus-accumbens-atrophy-to-plasticity-driven-rescue-of-motivation/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/from-neuroplasticity-to-symptom-relief-converging-mechanisms-driving-durable-therapeutic-benefit/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/lunch-networking-2/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/advancing-therapeutics-for-apathy-integrating-dopaminergic-non-dopaminergic-strategies-to-restore-motivation/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/transforming-psychiatric-care-from-psilocybin-breakthroughs-to-scalable-multi-indication-therapeutics/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/panel-discussion-ketamine-rapid-acting-antidepressants-plasticity-metabolites-the-next-generation-of-therapeutic-innovation/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/check-in-coffee-light-breakfast-3/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/chairs-opening-remarks-3/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/deciphering-muscarinic-mechanisms-advancing-beyond-applications-in-psychosis/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/panel-discussion-to-what-degree-does-neuroplasticity-underpin-psychedelic-efficacy/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/session-reserved-ulysses-neuroscience/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/morning-break-refreshments-2/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/end-of-conference-day-one/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/scientific-poster-session/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/chairs-closing-remarks/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/panel-discussion-future-directions-strategic-investment-to-fuel-the-next-wave-of-neuropsychiatric-therapeutics/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/session-reserved-transpharmation/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/panel-discussion-what-tools-can-be-used-to-demonstrate-efficacy-through-early-stage-clinical-trials-evaluating-digital-biomarkers-eeg-pros-fluid-measures-to-support-with-a-richer-analysis-of/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/from-early-stage-signals-to-strategic-capital-defining-the-technologies-investments-shaping-tomorrows-neuropsychiatry/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/afternoon-break-refreshments/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/from-domain-specific-biology-to-coas-advancing-endpoints-for-cognition-impulsivity/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/session-reserved-sama-therapeutics/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/advancing-early-neuroscience-trials-through-integrated-biomarkers-smarter-p1b-design/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/integrating-ai-to-advance-5-ht-receptor-driven-neuroplasticity-rewiring-neural-circuitry-with-next-generation-computational-neurotherapeutics/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/use-of-rwd-ai-for-stratifying-psychiatric-risk-treatment-matching/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/modulating-oxidative-stress-via-kat-ii-inhibition-phase-1-insights-from-kyn-5356-for-cognitive-impairment-in-schizophrenia/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/session-reserved-clerkenwell-health/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/mt1988-phase-2-insights-in-identifying-treating-cognitive-impairment-in-schizophrenia/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/lunch-networking/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/unravelling-the-therapeutic-potential-of-metabotropic-glutamate-receptor-7-mglu7-negative-allosteric-modulators-in-neuropsychiatric-disorders/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/roundtable-discussion-genetics-anchored-animal-models-as-a-new-foundation-for-psychosis-drug-discovery/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/harnessing-orexin-biology-to-advance-sleep-regulation-novel-neuropsychiatric-therapeutics/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/morning-break-refreshments/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/speed-networking/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/panel-discussion-neuropsychiatry-at-a-crossroads-where-science-strategy-deal-making-converge/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/beyond-symptoms-building-a-biology-first-framework-for-the-next-era-of-precision-psychiatry/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/advancing-mood-disorder-innovation-pipeline-expansion-regulatory-momentum-emerging-opportunities-in-neurotherapeutics/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/panel-discussion-overcoming-the-phase-2-3-roadblock-in-neuropsychiatric-drug-development-what-have-we-learnt-in-2026/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/where-precision-psychiatry-meets-smarter-development-modern-regulation-to-unlock-meaningful-patient-impact/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/chairs-opening-remarks-2/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/check-in-coffee-light-breakfast-2/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/chairs-closing-remarks-end-of-focus-day/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/panel-discussion-evaluating-unmet-needs-in-sleep-navigating-eeg-utility-limitations-across-complex-sleep-architecture/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/roundtable-discussion-interpreting-insomnia-signals-as-a-sleep-biomarker-across-mood-disorders/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/eeg-ai-to-identify-glutamatergic-responders-a-path-to-overcoming-schizophrenias-etiologic-heterogeneity-2/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/morning-networking-break/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/interpreting-insomnia-signals-as-a-sleep-biomarker-across-mood-disorders/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/roundtable-discussion-advancing-eeg-biomarkers-to-enhance-translational-precision-in-neuropsychiatric-drug-development/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/eeg-focus-day/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/precision-psychiatry-2-0-reimagining-frameworks-tools-clinical-pathways-to-deliver-individualized-mental-health-care/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/chairs-opening-remarks/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/how-do-we-commercialize-in-the-interventional-psychiatry-space-translating-interventional-psychiatry-into-practice-strategies-for-real-world-commercialization/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/lunch/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/pre-conference-workshop-day-2/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/check-in-coffee-light-breakfast/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/seminar/novel-endpoints-in-neuropsychiatry-redefining-how-we-measure-meaningful-clinical-change/ 2026-04-21T15:13:10+00:00 https://neuropsychiatric-drug-development.com/2026/01/20/dummy-blog-post/ 2026-01-20T23:26:07+00:00